Nataniel Phillips-Syivain
FDA investigator
Appears on 1 document from 2021, mostly at sites in Washington. Most often cites production record review (21 CFR 211.192).
- 1
- Documents on file
- —
- Observations per 483
- 2021
- First seen
- 2021
- Most recent
What they cite most
From 16 observations- 21 CFR 211.192Production record review3
- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.67Equipment cleaning and maintenance2
- 21 CFR 211.182Equipment cleaning and use log1
- 21 CFR 211.186Master production and control records1
- 21 CFR 211.194Laboratory records1
Activity by year
2021: 1
Where
Washington 1
Often inspects with
Is Nataniel Phillips-Syivain coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2021-03-19 | 483 AGC Biologics, Inc.Mar 19, 2021 · Bothell, Washington | Bothell, Washington | — |
About this profile
What does Nataniel Phillips-Syivain inspect?
Nataniel Phillips-Syivain appears on 1 document on file covering 1 site, mostly in Washington.
What do they cite most often?
21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and 21 CFR 211.67.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Nataniel Phillips-Syivain is dated Mar 19, 2021.